As of May 2024 Sangamo Therapeutics has a market cap of $0.12 Billion. This makes Sangamo Therapeutics the world's 7317th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.12 B | 24.93% |
2023 | $96.35 M | -81.28% |
2022 | $0.51 B | -52.9% |
2021 | $1.09 B | -50.5% |
2020 | $2.20 B | 127.38% |
2019 | $0.97 B | -17.26% |
2018 | $1.17 B | -15.37% |
2017 | $1.38 B | 543.51% |
2016 | $0.21 B | -66.47% |
2015 | $0.64 B | -38.85% |
2014 | $1.05 B | 21.5% |
2013 | $0.86 B | 171.12% |
2012 | $0.31 B | 113.99% |
2011 | $0.14 B | -50.54% |
2010 | $0.30 B | 13.12% |
2009 | $0.26 B | 86.78% |
2008 | $0.14 B | -72.83% |
2007 | $0.52 B | 126.96% |
2006 | $0.23 B | 87.74% |
2005 | $0.12 B | -18.75% |
2004 | $0.15 B | 11.08% |
2003 | $0.13 B | 83.3% |
2002 | $74.46 M | -67.43% |
2001 | $0.22 B |
On May 15th, 2024 the market cap of Sangamo Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $367.42 B | 305,132.07% | ๐บ๐ธ USA |
Amgen AMGN | $171.14 B | 142,074.06% | ๐บ๐ธ USA |
Biogen BIIB | $34.26 B | 28,362.26% | ๐บ๐ธ USA |
Dow DOW | $41.53 B | 34,401.19% | ๐บ๐ธ USA |
Gilead Sciences GILD | $83.48 B | 69,252.72% | ๐บ๐ธ USA |
Merck MRK | $333.64 B | 277,069.47% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $18.64 B | 15,388.83% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $15.26 B | 12,582.16% | ๐บ๐ธ USA |